CONTENTS OF THIS FILE
---------------------

 * Link to Results
 * Study Metadata
 * List of Files Included in Export
 * Cohort 1 Inclusion/Exclusion Criteria
 * Cohort 2 Inclusion/Exclusion Criteria

LINK TO RESULTS
---------------

 * https://live.trinetx.com/tnx/study/263622/analytics/684ae61c3615564ef3d0920b/outcomes/results


STUDY METADATA
--------------

 * Study Name: Transplant Urology Study
 * Analysis Name: Watchmen vs Coag 1 year 3.0
 * Analysis Type: Compare Outcomes
 * Cohort 1: ESRD and Watchmen
 * Cohort 2: Unnamed
 * Run by: Hunter Eby
 * Run on: Jun 12, 2025, 10:39 am
 * Network Name: US Collaborative Network
 * Patients on Network at Time of Analysis: 129,999,915
 * HCOs on Network at Time of Analysis: 71
 * HCOs Online for Analysis: 65
 * Last Data Refresh: Jun 12, 2025, 2:02 am
 * Outcome 1 Name: Unnamed Outcome
 * Outcome 2 Name: Unnamed Outcome
 * Outcome 3 Name: Unnamed Outcome
 * Outcome 4 Name: Unnamed Outcome
 * Outcome 5 Name: Unnamed Outcome
 * Outcome 6 Name: Unnamed Outcome


LIST OF FILES INCLUDED IN EXPORT
--------------------------------

 * Propensity_Score_Density_Graph_Small.png
 * Follow_up_metrics_matched_results_table.png
 * Follow_up_metrics_unmatched_results_table.png
 * Outcome_1_Result_a_MOA_table.png
 * Outcome_2_Result_a_MOA_table.png
 * Outcome_3_Result_a_MOA_table.png
 * Outcome_5_Result_a_MOA_table.png
 * Outcome_4_Result_a_MOA_table.png
 * Outcome_6_Result_a_MOA_table.png
 * Outcome_1_Result_b_KM_table.png
 * Propensity_Score_Density_Graph_Large.png
 * Propensity_Score_Density_Graph.csv
 * Follow_up_time_metrics_matched_results_graph_small.png
 * Follow_up_time_metrics_unmatched_results_graph_small.png
 * Outcome_1_Result_a_MOA_graph_small.png
 * Outcome_2_Result_a_MOA_graph_small.png
 * Outcome_3_Result_a_MOA_graph_small.png
 * Outcome_5_Result_a_MOA_graph_small.png
 * Outcome_4_Result_a_MOA_graph_small.png
 * Outcome_6_Result_a_MOA_graph_small.png
 * Outcome_1_Result_b_KM_graph_small.png
 * Follow_up_time_metrics_matched_results_graph_large.png
 * Follow_up_time_metrics_matched_results_table.csv
 * Follow_up_time_metrics_matched_results_graph.csv
 * Baseline_Patient_Characteristics.png
 * Baseline_Patient_Characteristics.csv
 * Follow_up_time_metrics_unmatched_results_graph_large.png
 * Follow_up_time_metrics_unmatched_results_table.csv
 * Follow_up_time_metrics_unmatched_results_graph.csv
 * Outcome_1_Result_a_MOA_graph_large.png
 * Outcome_1_Result_a_MOA_table.csv
 * Outcome_1_Result_a_MOA_graph.csv
 * Outcome_2_Result_a_MOA_graph_large.png
 * Outcome_2_Result_a_MOA_table.csv
 * Outcome_2_Result_a_MOA_graph.csv
 * Outcome_3_Result_a_MOA_graph_large.png
 * Outcome_3_Result_a_MOA_table.csv
 * Outcome_3_Result_a_MOA_graph.csv
 * Outcome_5_Result_a_MOA_graph_large.png
 * Outcome_5_Result_a_MOA_table.csv
 * Outcome_5_Result_a_MOA_graph.csv
 * Outcome_4_Result_a_MOA_graph_large.png
 * Outcome_4_Result_a_MOA_table.csv
 * Outcome_4_Result_a_MOA_graph.csv
 * Outcome_6_Result_a_MOA_graph_large.png
 * Outcome_6_Result_a_MOA_table.csv
 * Outcome_6_Result_a_MOA_graph.csv
 * Outcome_1_Result_b_KM_graph_large.png
 * Outcome_1_Result_b_KM_table.csv
 * Outcome_1_Result_b_KM_graph.csv


COHORT 1 INCLUSION/EXCLUSION CRITERIA
-------------------------------------

 * Must Have: (N18.6 End stage renal disease) AND I48 Atrial fibrillation and flutter

 * Cannot Have: 1008098 Renal Transplantation Procedures

 * Group 1

 * Group 1A: The terms in this group occurred at any time

 * Must Have: 33340 Percutaneous transcatheter closure of the left atrial appendage with endocardial implant, including fluoroscopy, transseptal puncture, catheter placement(s), left atrial angiography, left atrial appendage angiography, when performed, and radiological supervision and interpretation

 * Group 1B: Any instance of Group 1B occurred at least 46 days after any instance of Group 1A

 * Cannot Have: 1364430 apixaban OR 1599538 edoxaban OR 1037042 dabigatran etexilate OR 11289 warfarin OR 1114195 rivaroxaban



COHORT 2 INCLUSION/EXCLUSION CRITERIA
-------------------------------------

 * Must Have: (N18.6 End stage renal disease) AND I48 Atrial fibrillation and flutter

 * Cannot Have: 33340 Percutaneous transcatheter closure of the left atrial appendage with endocardial implant, including fluoroscopy, transseptal puncture, catheter placement(s), left atrial angiography, left atrial appendage angiography, when performed, and radiological supervision and interpretation OR 1008098 Renal Transplantation Procedures

 * Group 1: The terms in this group occurred at any time

 * Must Have: (1114195 rivaroxaban OR 1037042 dabigatran etexilate OR 1364430 apixaban OR 1599538 edoxaban)

 * OR

 * Group 2: The terms in this group occurred at any time

 * Must Have: 11289 warfarin AND 9032 INR in Plasma or Blood [1 - 4 years AND 2 - 3 {INR}, most recent value]

 * AND

 * Group 3

 * Group 3A: The terms in this group occurred at any time

 * Must Have: (1364430 apixaban OR 1599538 edoxaban OR 11289 warfarin OR 1114195 rivaroxaban OR 1037042 dabigatran etexilate)

 * Group 3B: Any instance of Group 3B occurred at least 5 years after any instance of Group 3A

 * Must Have: (1114195 rivaroxaban OR 1037042 dabigatran etexilate OR 11289 warfarin OR 1364430 apixaban OR 1599538 edoxaban)



Generated by TriNetX